Intense and recurrent déjà vu experiences related to amantadine and phenylpropanolamine in a healthy male

      This paper is only available as a PDF. To read, Please Download here.


      We report a case of a 39-year-old caucasian healthy male physician who developed intense and recurrent déjà vu experiences within 24h of initiating concomitant amantadine–phenylpropanolamine treatment against influenza. Déjà vu experiences terminated on discontinuation of medication. Findings in temporal epilepsy suggest that mesial temporal structures, including hippocampus, are rel ated to paramnesic symptoms. On the other hand, previous case reports have confirmed that both amantadine and phenylpropanolamine alone, and particularly in combination, can induce psychotic symptoms due to their dopaminergic activity. The authors sugges t that déjà vu experiences may be provoked by increased dopamine activity in mesial temporal structures of the brain.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Clinical Neuroscience
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Huber TJ
        • Dietrich DE
        • Emrich HM
        Possible use of amantadine in depression.
        Pharmacopsychiatry. 1999; 32:: 47-55
        • Nickels JL
        • Schneider WN
        • Dombovy ML
        • Wong TM
        Clinical use of amantadine in brain injury rehabilitation.
        Brain Inj. 1994; 8: 709-718
        • Valevski A
        • Modai I
        • Zbarski E
        • Zemishlany Z
        • Weizman A
        Effect of amantadine on sexual dysfunction in neuroleptic-treated male schizophrenic patients.
        Clin Neuropharmacol. 1998; 21: 355-357
        • Deep P
        • Dagher A
        • Sadikot A
        • Gjedde A
        • Cumming P
        Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary toNMDA receptor antagonism with a low dose of amantadine.
        Synapse. 1999; 34: 313-318
        • Flaherty JA
        • Bellur SN
        Mental side effects of amantadine therapy: its spectrum and characteristics in a normal population.
        J Clin Psychiatry. 1981; 42:: 345
        • Marshall RD
        • Douglas CJ
        Phenylpropanolamine-induced psychosis: potential predisposing factors.
        Gen Hosp Psychiatry. 1994; 16: 358-360
        • Neppe VM
        The psychology of déjà vu: have I been here before? Witwaterstrand University Press, Johannesburg1983
        • Fish DR
        Psychic seizures.
        in: Engel J Pedley TA Epilepsy: a comprehensive textbook. Volume 1. Lippincott-Raven, Philadelphia1997: 543-548
        • Ardila A
        • Nino CR
        • Pulido E
        • Rivera DB
        • Vanegras CJ
        Episodic psychic symptoms in the general population.
        Epilepsia. 1993; 34: 133-140
        • Richardson TF
        • Winokur G
        Déjà vu as related to diagnostic categories in psychiatric and neurosurgical patients.
        J Nerv Ment Dis. 1968; 146: 161-164
        • Sno HN
        • Linszen DH
        • De Jonghe F
        Déjà vu experiences and reduplicative paramnesia.
        Br J Psychiatry. 1992; 161: 565-568
        • First MB
        • Spitzer RL
        • Gibbon M
        • Williams BW
        Structured Clinical Interview for DSM-IV Axis I Disorders – Patient Edition (SCID-I/P, Version 2.0, 4/97 revision). Biometrics Research Department, New York State Psychiatric Institute, New York1997
        • First MB
        • Spitzer RL
        • Gibbon M
        • Williams BW
        • Benjamin L
        Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). Biometrics Research Department, New York State Psychiatric Institute, New York1997
        • Bernstein EM
        • Putnam FW
        Development, reliability, and validity of a dissociation scale.
        J Nerv Ment Dis. 1986; 174: 727-735
        • Stroe AE
        • Hall J
        • Amin F
        Psychotic episode related to phenylpropanolamine and amantadine in a healthy female.
        Gen Hosp Psychiatry. 1995; 17: 457-458
        • Laakso A
        • Vilkman H
        • Kajander J
        • Bergman J
        • Haaparanta M
        • Solin J
        • Hietala J
        Prediction of detached personality in healthy subjects by low dopamine transporter binding.
        Am J Psychiatry. 2000; 157: 290-292
        • Wilkerson A
        • Levin ED
        Ventral hippocampal dopamine D1and D2systems and spatial working memory in rats.
        Neuroscience. 1999; 89: 743-749